Walmart Launches Private-Brand Insulin
June 29 2021 - 9:05AM
Dow Jones News
By Dave Sebastian
Walmart Inc. said it launched a private-brand analog insulin,
with Novo Nordisk A/S-made insulin aspart injections available in
the retail giant's pharmacies this week.
The injections are available through Walmart's private ReliOn
brand, with analog insulin vials retailing at $72.88 and FlexPen at
$85.88, the company said Tuesday.
The insulin aspart injection will be available in Sam's Club
pharmacies in mid-July across the U.S., Walmart said. Customers
will need a prescription to buy the products, the company said.
Write to Dave Sebastian at dave.sebastian@wsj.com
(END) Dow Jones Newswires
June 29, 2021 08:54 ET (12:54 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
Walmart (NYSE:WMT)
Historical Stock Chart
From Mar 2024 to Apr 2024
Walmart (NYSE:WMT)
Historical Stock Chart
From Apr 2023 to Apr 2024